[HTML][HTML] Inhibiting interleukin-6 to reduce cardiovascular event rates: a next step for atherothrombosis treatment and prevention
PM Ridker - Journal of the American College of Cardiology, 2021 - jacc.org
In the rapidly evolving story of inflammation and atherothrombosis, all roads seem to
converge on interleukin (IL)-6, a central signaling cytokine of innate immunity (1). More than …
converge on interleukin (IL)-6, a central signaling cytokine of innate immunity (1). More than …
[引用][C] Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates
PM Ridker - Journal of the American College of Cardiology, 2021 - cir.nii.ac.jp
Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention
PM Ridker - Journal of the American College of …, 2021 - pubmed.ncbi.nlm.nih.gov
Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis
Treatment and Prevention Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A …
Treatment and Prevention Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A …
[引用][C] Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention.
PM Ridker - Journal of the American College of Cardiology, 2021 - europepmc.org
Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis
Treatment and Prevention. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Treatment and Prevention. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …